Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
MousePheno	impaired wound healing	PLEC FN1 AEBP1 NBEAL2	5.36e-06	42	39	4	MP:0001792
Domain	ABC1	ADCK2 COQ8B	6.44e-05	5	48	2	PF03109
Domain	UbiB_dom	ADCK2 COQ8B	6.44e-05	5	48	2	IPR004147
Domain	Sema	SEMA4D PLXNC1	2.87e-03	31	48	2	SM00630
Domain	Semap_dom	SEMA4D PLXNC1	2.87e-03	31	48	2	IPR001627
Domain	Sema	SEMA4D PLXNC1	2.87e-03	31	48	2	PF01403
Domain	SEMA	SEMA4D PLXNC1	2.87e-03	31	48	2	PS51004
Domain	PSI	SEMA4D PLXNC1	3.05e-03	32	48	2	PF01437
Domain	Plexin_repeat	SEMA4D PLXNC1	3.05e-03	32	48	2	IPR002165
Domain	C2-set_2	MAG KIRREL3	4.98e-03	41	48	2	PF08205
Domain	CD80_C2-set	MAG KIRREL3	4.98e-03	41	48	2	IPR013162
Domain	PSI	SEMA4D PLXNC1	5.71e-03	44	48	2	IPR016201
Pathway	PID_INTEGRIN_A4B1_PATHWAY	PRKAR1B PTPRA FN1	6.66e-05	33	34	3	M277
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	LENG8 BAZ1B NFS1 EMSY TP53BP1 IPO11 SUPT16H	4.27e-07	341	48	7	32971831
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	LENG8 BAZ1B SET CDC42BPB TP53BP1 SUPT16H	1.27e-06	251	48	6	31076518
Pubmed	Fibronectin is a binding partner for the myelin-associated glycoprotein (siglec-4a).	MAG FN1	1.87e-06	2	48	2	11423128
Pubmed	Proteomic identification of plasma protein tyrosine phosphatase alpha and fibronectin associated with liver fluke, Opisthorchis viverrini, infection.	PTPRA FN1	1.87e-06	2	48	2	23029023
Pubmed	The molecular anatomy of mammalian upper lip and primary palate fusion at single cell resolution.	RERG ALDH1A2 ADAMTS9	2.77e-06	20	48	3	31118233
Pubmed	LncRNA ADAMTS9-AS2 regulates periodontal ligament cell migration under mechanical compression via ADAMTS9/fibronectin.	FN1 ADAMTS9	5.59e-06	3	48	2	37957805
Pubmed	Expression of tenascin in developing and adult mouse lymphoid organs.	FN1 TNXB	5.59e-06	3	48	2	7687262
Pubmed	Not just scaffolding: plectin regulates actin dynamics in cultured cells.	ACTG2 PLEC	5.59e-06	3	48	2	9808630
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CNRIP1 PRKAR1B SRGAP2 CDC42BPB NPEPPS EMSY TP53BP1 TAGLN3 SUPT16H	5.86e-06	963	48	9	28671696
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	SET PLEC NPEPPS TP53BP1 IPO11 SUPT16H	7.75e-06	344	48	6	30333137
Pubmed	A subcellular map of the human kinome.	ADCK2 COQ8B	1.12e-05	4	48	2	33988507
Pubmed	Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1.	PPME1 SET	1.12e-05	4	48	2	32071079
Pubmed	TNF-alpha suppresses alpha-smooth muscle actin expression in human dermal fibroblasts: an implication for abnormal wound healing.	ACTG2 FN1	1.86e-05	5	48	2	17554369
Pubmed	Semaphorin 7A promotes axon outgrowth through integrins and MAPKs.	FN1 PLXNC1	1.86e-05	5	48	2	12879062
Pubmed	A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis.	TNXB EMSY	3.90e-05	7	48	2	23886662
Pubmed	Mice develop normally without tenascin.	FN1 TNXB	5.19e-05	8	48	2	1383086
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	CNRIP1 PPME1 SEMA4D SRGAP2 PTPRA PLEC FN1 ADAMTS9 CDC42BPB	5.70e-05	1285	48	9	35914814
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	SET PLEC FN1 ADAMTS9 CDC42BPB SUPT16H	6.10e-05	497	48	6	23414517
Pubmed	Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins.	ACTG2 FN1	6.67e-05	9	48	2	9827803
Pubmed	Brn3a and Nurr1 mediate a gene regulatory pathway for habenula development.	TSPAN12 AEBP1 PLXNC1 COQ8B	8.27e-05	166	48	4	19906978
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	FN1 ADAMTS9 TNXB	9.69e-05	64	48	3	22261194
Pubmed	The transmembrane semaphorin Sema4D/CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion.	MAG SEMA4D	1.02e-04	11	48	2	14534257
Pubmed	Noses and neurons: induction, morphogenesis, and neuronal differentiation in the peripheral olfactory pathway.	ALDH1A2 FN1	1.22e-04	12	48	2	16193510
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	SRGAP2 PLEC CDC42BPB EMSY TP53BP1	1.37e-04	360	48	5	33111431
Pubmed	UIF, a New mRNA export adaptor that works together with REF/ALY, requires FACT for recruitment to mRNA.	SET SUPT16H	1.44e-04	13	48	2	19836239
Pubmed	Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates.	SEMA4D PLXNC1	1.44e-04	13	48	2	10520995
Pubmed	FACT facilitates chromatin transcription by RNA polymerases I and III.	POLR2H SUPT16H	1.44e-04	13	48	2	19214185
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	PRKAR1B PPME1 SEC24D SET PLEC NPEPPS IPO11 POLR2H SUPT16H	1.47e-04	1455	48	9	22863883
Pubmed	Retinoic acid selectively inhibits death of basal vomeronasal neurons during late stage of neural circuit formation.	KIRREL3 ALDH1A2	1.68e-04	14	48	2	19519663
Pubmed	Impaired ADAMTS9 secretion: A potential mechanism for eye defects in Peters Plus Syndrome.	FN1 ADAMTS9	1.68e-04	14	48	2	27687499
Pubmed	Signaling hierarchy downstream of retinoic acid that independently regulates vascular remodeling and endothelial cell proliferation.	ALDH1A2 FN1	1.68e-04	14	48	2	15175265
Pubmed	Sprouty1 haploinsufficiency prevents renal agenesis in a model of Fraser syndrome.	FN1 FREM1	1.94e-04	15	48	2	23064016
Pubmed	Visceral endoderm function is regulated by quaking and required for vascular development.	ALDH1A2 FN1	1.94e-04	15	48	2	16470614
Pubmed	Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.	ADCK2 PLEC FN1 ARNT2	2.19e-04	214	48	4	22199357
Pubmed	Non-muscle myosin IIB (Myh10) is required for epicardial function and coronary vessel formation during mammalian development.	ALDH1A2 FN1	2.21e-04	16	48	2	29084269
Pubmed	Allocation of paraventricular and supraoptic neurons requires Sim1 function: a role for a Sim1 downstream gene PlexinC1.	PLXNC1 ARNT2	2.21e-04	16	48	2	17356169
Pubmed	Identification of Greb1l as a genetic determinant of crisscross heart in mice showing torsion of the heart tube by shortage of progenitor cells.	ALDH1A2 FN1	2.21e-04	16	48	2	37852253
Pubmed	Comprehensive proteomic characterization of stem cell-derived extracellular matrices.	FN1 AEBP1 TNXB	2.33e-04	86	48	3	28327460
Pubmed	Characterization of 16 novel human genes showing high similarity to yeast sequences.	ATP9B NFS1	2.50e-04	17	48	2	11124703
Pubmed	The cleavage of host cell proteins by HIV-1 protease.	ACTG2 FN1	2.50e-04	17	48	2	8997639
Pubmed	Will diverse Tat interactions lead to novel antiretroviral drug targets?	PRKAR1B POLR2H	2.50e-04	17	48	2	17168834
Pubmed	Proteomic characterization of chromosomal common fragile site (CFS)-associated proteins uncovers ATRX as a regulator of CFS stability.	BAZ1B ACTG2 PLEC FN1 POLR2H SUPT16H	2.67e-04	652	48	6	31180492
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	LENG8 BAZ1B PPME1 SRGAP2 ALDH1A2 EMSY TP53BP1	2.78e-04	934	48	7	33916271
Pubmed	The ATG5 interactome links clathrin-mediated vesicular trafficking with the autophagosome assembly machinery.	SET AEBP1 CDC42BPB SUPT16H	2.89e-04	230	48	4	35449600
Pubmed	A large multiethnic GWAS meta-analysis of cataract identifies new risk loci and sex-specific effects.	SEMA4D PLEC	3.49e-04	20	48	2	34127677
Pubmed	Proteomics characterization of extracellular space components in the human aorta.	FN1 AEBP1 TNXB	3.74e-04	101	48	3	20551380
Pubmed	Prohibitin regulates TGF-beta induced apoptosis as a downstream effector of Smad-dependent and -independent signaling.	PLEC IPO11	3.85e-04	21	48	2	19725029
Pubmed	Mohawk promotes the maintenance and regeneration of the outer annulus fibrosus of intervertebral discs.	FN1 TNXB	4.23e-04	22	48	2	27527664
Pubmed	Epicardial function of canonical Wnt-, Hedgehog-, Fgfr1/2-, and Pdgfra-signalling.	ALDH1A2 FN1	4.23e-04	22	48	2	24000064
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	LENG8 PPME1 ADCK2 RERE PTPRA C2orf68 EMSY SUPT16H	4.26e-04	1327	48	8	32694731
Pubmed	Direct binding of CoREST1 to SUMO-2/3 contributes to gene-specific repression by the LSD1/CoREST1/HDAC complex.	BAZ1B TP53BP1 SUPT16H	4.31e-04	106	48	3	19394292
Pubmed	Secreted metalloproteases ADAMTS9 and ADAMTS20 have a non-canonical role in ciliary vesicle growth during ciliogenesis.	FN1 ADAMTS9	4.63e-04	23	48	2	30814516
Pubmed	ADAMTS9-Mediated Extracellular Matrix Dynamics Regulates Umbilical Cord Vascular Smooth Muscle Differentiation and Rotation.	FN1 ADAMTS9	4.63e-04	23	48	2	26027930
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	BAZ1B DHX33 PLEC FN1 NPEPPS TP53BP1 POLR2H SUPT16H	4.85e-04	1353	48	8	29467282
Pubmed	Insights into the ubiquitin-proteasome system of human embryonic stem cells.	SRGAP2 PLEC AEBP1 IPO11	5.21e-04	269	48	4	29511261
Pubmed	Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis.	MAG FN1	5.48e-04	25	48	2	19373938
Pubmed	PlexinA1 signaling directs the segregation of proprioceptive sensory axons in the developing spinal cord.	MAG SEMA4D PLXNC1	5.75e-04	117	48	3	17145500
Pubmed	Semaphorin heterodimerization in cis regulates membrane targeting and neocortical wiring.	SEMA4D PLXNC1	5.93e-04	26	48	2	39152101
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	BAZ1B SET EMSY SUPT16H	6.30e-04	283	48	4	30585729
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	BAZ1B SET SRGAP2 PLEC FN1 KCNJ8 TP53BP1	6.76e-04	1084	48	7	11544199
Pubmed	Expression of Robo/Slit and Semaphorin/Plexin/Neuropilin family members in the developing hypothalamic paraventricular and supraoptic nuclei.	SEMA4D PLXNC1	6.89e-04	28	48	2	18617019
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MAG SRGAP2 PTPRA PLEC FN1 CDC42BPB NPEPPS TAGLN3	7.01e-04	1431	48	8	37142655
Pubmed	Fezl regulates the differentiation and axon targeting of layer 5 subcortical projection neurons in cerebral cortex.	SEMA4D PLXNC1 ARNT2	7.13e-04	126	48	3	16284245
Pubmed	Basement membrane assembly of the integrin α8β1 ligand nephronectin requires Fraser syndrome-associated proteins.	FN1 FREM1	7.39e-04	29	48	2	22613833
Pubmed	EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation.	PLEC CDC42BPB TP53BP1	7.46e-04	128	48	3	23858473
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	LENG8 PPME1 SET NPEPPS EMSY TP53BP1 IPO11	7.49e-04	1103	48	7	34189442
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	SEC24D RERE PLEC NFS1 FN1 CLCN5 AEBP1 SUPT16H	7.67e-04	1451	48	8	30550785
Pubmed	Wnt/β-catenin signaling maintains the mesenchymal precursor pool for murine sinus horn formation.	ALDH1A2 FN1	8.45e-04	31	48	2	21757651
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	FN1 AEBP1 TNXB	8.71e-04	135	48	3	28675934
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PRKAR1B SEMA4D ATP9B SRGAP2 RERE CDC42BPB NPEPPS PCDHB16	9.07e-04	1489	48	8	28611215
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	LENG8 BAZ1B SET SRGAP2 DHX33 CDC42BPB EMSY POLR2H	9.39e-04	1497	48	8	31527615
Pubmed	Lhx2 is a direct NF-κB target gene that promotes primary hair follicle placode down-growth.	FN1 FREM1	9.58e-04	33	48	2	26952977
Pubmed	The RNA polymerase II elongation complex.	POLR2H SUPT16H	9.58e-04	33	48	2	12676794
Pubmed	Regulation of prefrontal patterning and connectivity by retinoic acid.	ALDH1A2 PLXNC1	1.02e-03	34	48	2	34599305
Pubmed	Wnt5a and Wnt11 regulate mammalian anterior-posterior axis elongation.	ALDH1A2 FN1	1.08e-03	35	48	2	25813538
Pubmed	Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.	FN1 AEBP1 TNXB	1.09e-03	146	48	3	27068509
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	MAG PTPRA PLXNC1 CDC42BPB NBEAL2	1.10e-03	569	48	5	30639242
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	BAZ1B PLEC CDC42BPB SUPT16H	1.14e-03	332	48	4	37433992
Pubmed	Fog2 is critical for cardiac function and maintenance of coronary vasculature in the adult mouse heart.	ALDH1A2 FN1	1.14e-03	36	48	2	19411759
Pubmed	Galnt1 is required for normal heart valve development and cardiac function.	FN1 ADAMTS9	1.14e-03	36	48	2	25615642
Pubmed	ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.	SET TP53BP1 SUPT16H	1.18e-03	150	48	3	28242625
Pubmed	Mesenchymal FGFR1 and FGFR2 control patterning of the ureteric mesenchyme by balancing SHH and BMP4 signaling.	ACTG2 ALDH1A2	1.20e-03	37	48	2	36094016
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	ATP9B PLEC FREM1	1.23e-03	152	48	3	34299191
Pubmed	Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.	FN1 AEBP1 TNXB	1.25e-03	153	48	3	25037231
Pubmed	Control of cardiac jelly dynamics by NOTCH1 and NRG1 defines the building plan for trabeculation.	FN1 ADAMTS9	1.27e-03	38	48	2	29743679
Pubmed	Analysis of Ku70 S155 Phospho-Specific BioID2 Interactome Identifies Ku Association with TRIP12 in Response to DNA Damage.	BAZ1B SET NPEPPS	1.32e-03	156	48	3	37108203
Pubmed	The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA.	LENG8 BAZ1B DHX33 SUPT16H	1.37e-03	349	48	4	25665578
CoexpressionAtlas	Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2	TSPAN12 ACTG2 OLFML2A RERG SEC24D FN1 AEBP1 TNXB	7.20e-06	453	48	8	GSM777067_500
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4	CNRIP1 PRKAR1B OLFML2A ADCK2 RERG SEC24D ALDH1A2 FN1 FREM1 PCDHB16 TAGLN3	3.91e-05	1148	48	11	facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_100	ALDH1A2 PLXNC1 FREM1	7.34e-05	36	48	3	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_100
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#4_top-relative-expression-ranked_100	ALDH1A2 PLXNC1	1.04e-04	7	48	2	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k4_100
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500	ALDH1A2 FN1 AEBP1 ADAMTS9 PLXNC1 FREM1	1.44e-04	356	48	6	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500
CoexpressionAtlas	dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_500	ACTG2 ALDH1A2 FN1 FREM1 KCNJ8 TAGLN3	1.80e-04	371	48	6	gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_500
CoexpressionAtlas	dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_500	ALDH1A2 FN1 FREM1 KCNJ8	1.94e-04	127	48	4	gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k2_500
CoexpressionAtlas	gudmap_RNAseq_e15.5_Podocytes_2500_K0	CNRIP1 ACTG2 SEC24D ALDH1A2 ADAMTS9 MYCBPAP CDC42BPB FREM1 KCNJ8 PCDHB16	1.97e-04	1143	48	10	gudmap_RNAseq_e15.5_Podocytes_2500_K0
CoexpressionAtlas	dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#2_top-relative-expression-ranked_1000	ALDH1A2 ADAMTS9 PLXNC1	2.48e-04	54	48	3	gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k2_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_200	ALDH1A2 ADAMTS9 PLXNC1 FREM1	2.66e-04	138	48	4	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_200
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_1000	RERG ALDH1A2 ADAMTS9 PLXNC1	2.66e-04	138	48	4	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_1000
CoexpressionAtlas	dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000	ALDH1A2 FN1 ADAMTS9 FREM1 KCNJ8	3.00e-04	261	48	5	gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_500	ALDH1A2 ADAMTS9 PLXNC1	3.07e-04	58	48	3	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_500
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000	RERG SEC24D ALDH1A2 FN1 AEBP1 ADAMTS9 PLXNC1 FREM1	3.09e-04	773	48	8	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	SEC24D SET ALDH1A2 FN1 AEBP1 ADAMTS9 PLXNC1 FREM1	3.20e-04	777	48	8	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2	CNRIP1 PRKAR1B ADCK2 RERG SEC24D FN1 FREM1 PCDHB16 TAGLN3 COQ8B	3.51e-04	1228	48	10	facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	SEC24D SET ALDH1A2 FN1 AEBP1 ADAMTS9 PLXNC1 FREM1	3.66e-04	793	48	8	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000	ACTG2 UNC13C ALDH1A2 PLEC AEBP1 ADAMTS9 TNXB KCNJ8	3.79e-04	797	48	8	gudmap_developingGonad_P2_epididymis_1000
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_100	UNC13C ADAMTS9 PLXNC1	4.10e-04	64	48	3	gudmap_developingGonad_P2_ovary_100
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#2	SEMA4D SET NBEAL2	4.29e-04	65	48	3	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K2
CoexpressionAtlas	kidney_P0_JuxtaGlom_Ren1_k-means-cluster#4_top-relative-expression-ranked_200	ACTG2 FN1 KCNJ8	4.90e-04	68	48	3	gudmap_kidney_P0_JuxtaGlom_Ren1_k4_200
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_100	ALDH1A2 PLXNC1 FREM1	4.90e-04	68	48	3	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_100
CoexpressionAtlas	Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4	TSPAN12 OLFML2A FN1 AEBP1 ADAMTS9 CDC42BPB	5.06e-04	450	48	6	GSM777063_500
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#1_top-relative-expression-ranked_200	ALDH1A2 PLXNC1	5.16e-04	15	48	2	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k1_200
CoexpressionAtlas	dev lower uro neuro_e14.5_PelvicGanglion_Sox10_top-relative-expression-ranked_500	ACTG2 ALDH1A2 FN1 FREM1 KCNJ8 TAGLN3	5.88e-04	463	48	6	gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_500
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_100	ALDH1A2 PLXNC1 FREM1	6.03e-04	73	48	3	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_100
CoexpressionAtlas	DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000	RERG SET PLXNC1 FREM1 KCNJ8 TP53BP1 IPO11 ARNT2	6.04e-04	855	48	8	gudmap_developingKidney_e13.5_podocyte cells_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_100	ALDH1A2 PLXNC1 FREM1	6.53e-04	75	48	3	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_100
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#3_top-relative-expression-ranked_100	ALDH1A2 FREM1	7.48e-04	18	48	2	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k3_100
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#3_top-relative-expression-ranked_1000	ALDH1A2 AEBP1 PLXNC1	7.60e-04	79	48	3	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k3_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#1_top-relative-expression-ranked_1000	ALDH1A2 ADAMTS9 PLXNC1	8.47e-04	82	48	3	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k1_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_100	ALDH1A2 PLXNC1 FREM1	8.47e-04	82	48	3	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_100
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_1000	RERG ALDH1A2 ADAMTS9 PLXNC1	9.06e-04	191	48	4	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k4_1000
CoexpressionAtlas	dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#1_top-relative-expression-ranked_200	PLXNC1 FREM1	9.26e-04	20	48	2	gudmap_dev gonad_e11.5_F_GonMes_Sma_k1_200
ToppCell	facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTG2 RERG SEC24D ALDH1A2 FN1 AEBP1 ADAMTS9 FREM1	3.51e-11	195	48	8	18b01ab63ee1deae3cf29669d66fff9ca4efc5c4
ToppCell	COVID-19-kidney-PEC\|kidney / Disease (COVID-19 only), tissue and cell type	TSPAN12 RERG KIRREL3 ALDH1A2 AEBP1 ARNT2	3.07e-08	172	48	6	36a96714a0eb6ac438648135336c9791881ddadb
ToppCell	droplet-Kidney-nan-18m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RERG ALDH1A2 FN1 AEBP1 TNXB FREM1	5.90e-08	192	48	6	38d7a24ae205ef91ed2e0f402d8022f2a9cdb243
ToppCell	droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RERG ALDH1A2 FN1 AEBP1 TNXB FREM1	5.90e-08	192	48	6	04d155897ed075c359933080e36a4ab2150b6e9f
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TSPAN12 RERG KIRREL3 ALDH1A2 AEBP1 TAGLN3	6.67e-08	196	48	6	34e79918a448f6c19b87e1b1ce13c012b24be1f8
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TSPAN12 RERG KIRREL3 ALDH1A2 AEBP1 TAGLN3	6.67e-08	196	48	6	8f82e01ca50aa4cd6149547505b4474a02fad618
ToppCell	Endothelial-B-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	OLFML2A AEBP1 ADAMTS9 TNXB IPO11	1.29e-06	176	48	5	b288116a4588a1f9db9d49af92cea118937c9201
ToppCell	COVID-19-kidney-Epi_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	RERG KIRREL3 ALDH1A2 AEBP1 ARNT2	1.40e-06	179	48	5	e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d
ToppCell	facs-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC13C ALDH1A2 FN1 AEBP1 ADAMTS9	1.44e-06	180	48	5	12537d8a569faa69f474284d2c201475722b8ca1
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ACTG2 RERG UNC13C FN1 AEBP1	1.48e-06	181	48	5	d7e04e0ca549eac6d9b1192b6578f9b54943d54f
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ACTG2 RERG FN1 AEBP1 TNXB	1.48e-06	181	48	5	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TSPAN12 RERG KIRREL3 ALDH1A2 ARNT2	1.48e-06	181	48	5	5f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TSPAN12 RERG KIRREL3 ALDH1A2 ARNT2	1.48e-06	181	48	5	c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RERG KIRREL3 ALDH1A2 AEBP1 ARNT2	1.65e-06	185	48	5	34fcfd635c828dad9643bbf1c908d79282d6f5d9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RERG KIRREL3 ALDH1A2 AEBP1 ARNT2	1.65e-06	185	48	5	8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	OLFML2A FN1 AEBP1 TNXB FREM1	1.74e-06	187	48	5	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TSPAN12 RERG KIRREL3 ALDH1A2 ARNT2	1.79e-06	188	48	5	b21e93a70583c30d05c0833cd3d4d4bca44a039e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TSPAN12 RERG KIRREL3 ALDH1A2 ARNT2	1.79e-06	188	48	5	874404a4fd9aa42873f6c53dc42da22d3b0fdb9e
ToppCell	10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ACTG2 RERG FN1 ADAMTS9 KCNJ8	1.83e-06	189	48	5	1ff4f8da572bdc6356e9df9f41a7f62c81d4c570
ToppCell	tumor_Lung-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	TSPAN12 ACTG2 OLFML2A ADAMTS9 KCNJ8	1.83e-06	189	48	5	9c407b17d7945e81e1ae6c18452f5d20fb09d563
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	RERG FN1 AEBP1 TNXB FREM1	1.88e-06	190	48	5	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	facs-Aorta-Heart-3m-Mesenchymal-fibroblast\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEC24D ALDH1A2 FN1 AEBP1 TNXB	1.93e-06	191	48	5	9214655dca96d766737c9f30b624d7fe7050342e
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ACTG2 ALDH1A2 AEBP1 TNXB FREM1	1.93e-06	191	48	5	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TSPAN12 CNRIP1 ACTG2 RERG FN1	1.93e-06	191	48	5	89d03c4133dda852a3713c0902a7d67941cf5b21
ToppCell	droplet-Kidney-nan-18m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RERG ALDH1A2 FN1 AEBP1 TNXB	1.98e-06	192	48	5	84149a5c6c3b3c9b86aed77cf8e72d99ef099fab
ToppCell	droplet-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RERG UNC13C ALDH1A2 FN1 AEBP1	2.03e-06	193	48	5	2d891c00b8f0aace17d4c300b63e2341dcffa199
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	RERG FN1 AEBP1 TNXB FREM1	2.03e-06	193	48	5	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	LA\|World / Chamber and Cluster_Paper	ACTG2 RERG KIRREL3 FN1 TNXB	2.03e-06	193	48	5	d4bf89437216baf489ea0239136dcedf3b6714af
ToppCell	metastatic_Brain-Fibroblasts-Pericytes\|metastatic_Brain / Location, Cell class and cell subclass	ACTG2 OLFML2A FN1 AEBP1 KCNJ8	2.09e-06	194	48	5	d1889a3e22d5b88461c81ec3ea0e74bb9bf63e60
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ACTG2 RERG FN1 AEBP1 TNXB	2.09e-06	194	48	5	8fae8061b350336299aa81f378e07deadbd55123
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ACTG2 OLFML2A UNC13C FN1 KCNJ8	2.09e-06	194	48	5	a7731378f44ca1a229311686caf5740c742d21ba
ToppCell	COVID-19-Heart-Fib_2\|Heart / Disease (COVID-19 only), tissue and cell type	RERG KIRREL3 FN1 AEBP1 TNXB	2.09e-06	194	48	5	d91c9f2ec47319051fc398320693fddbe8bbd4d6
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	OLFML2A RERG UNC13C FN1 FREM1	2.09e-06	194	48	5	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ACTG2 RERG FN1 AEBP1 TNXB	2.09e-06	194	48	5	4d7d24390fdb379f943ddcc70a63f23955e10163
ToppCell	COVID-19-Heart-Fib_1\|Heart / Disease (COVID-19 only), tissue and cell type	RERG ALDH1A2 FN1 TNXB FREM1	2.14e-06	195	48	5	f423baa36ac7cdc383c033e35a7d17e6bf913323
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	RERG FN1 AEBP1 TNXB FREM1	2.14e-06	195	48	5	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTG2 RERG ALDH1A2 FN1 AEBP1	2.14e-06	195	48	5	095b8e0be385b6390420589124a95fa4ba3682ab
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ACTG2 OLFML2A UNC13C FN1 KCNJ8	2.19e-06	196	48	5	9a420a4eb46cb554bec641726fea5398ff60f630
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RERG FN1 AEBP1 TNXB FREM1	2.19e-06	196	48	5	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OLFML2A SEC24D FN1 AEBP1 TNXB	2.19e-06	196	48	5	2029f58ce6a7b8c35d3a7496c3341391990909ce
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ACTG2 RERG ALDH1A2 AEBP1 ADAMTS9	2.25e-06	197	48	5	3332b9b5bf78f0203ebbd94257a36e9054d896c3
ToppCell	droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTG2 RERG ALDH1A2 FN1 AEBP1	2.25e-06	197	48	5	86145bc1e585b4ae136e755cafd6579da2abfa65
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ACTG2 OLFML2A RERG FN1 KCNJ8	2.25e-06	197	48	5	983502a99e6d59bb36225b0246a9990604de1a01
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ACTG2 RERG FN1 AEBP1 TNXB	2.25e-06	197	48	5	16758f181ef07c60aee63072e1da9572c5c85414
ToppCell	343B-Fibroblasts-Fibroblast-K_(Pericytes)\|343B / Donor, Lineage, Cell class and subclass (all cells)	ACTG2 RERG ALDH1A2 FN1 AEBP1	2.25e-06	197	48	5	78d45d11820ec379942c4c3defd619d5f8cc8e1f
ToppCell	343B-Fibroblasts-Fibroblast-K_(Pericytes)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	ACTG2 RERG ALDH1A2 FN1 AEBP1	2.25e-06	197	48	5	31bc9fd679d78550541d4158568e8dd09ff29e8e
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	RERG FN1 AEBP1 TNXB FREM1	2.30e-06	198	48	5	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RERG KIRREL3 ALDH1A2 AEBP1 TAGLN3	2.36e-06	199	48	5	b9338b739162cd8e5661c9a4dcb41a31219b5723
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	RERG FN1 AEBP1 TNXB FREM1	2.36e-06	199	48	5	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ACTG2 FN1 AEBP1 ADAMTS9 PCDHB16	2.36e-06	199	48	5	8ff0fdcbe9661b013913731ec8b53d84836ca865
ToppCell	(5)_Fibroblast-G\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	OLFML2A RERG FN1 AEBP1 TNXB	2.36e-06	199	48	5	b4a737575be9f8c65771832dd8cd25328d5dae0d
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RERG KIRREL3 ALDH1A2 AEBP1 TAGLN3	2.36e-06	199	48	5	c972d3036151403f26fa9d6271520639c281ab84
ToppCell	343B-Fibroblasts\|343B / Donor, Lineage, Cell class and subclass (all cells)	ACTG2 RERG FN1 AEBP1 TNXB	2.42e-06	200	48	5	376c1a77031e090be96948b47c78ac0d393f5775
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RERG FN1 AEBP1 TNXB FREM1	2.42e-06	200	48	5	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	(6)_Stroma\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	ACTG2 FN1 AEBP1 TNXB KCNJ8	2.42e-06	200	48	5	f9baef67dde62f1c161a9408a78f635ea70ea9d3
ToppCell	(6)_Stroma\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	ACTG2 FN1 AEBP1 TNXB KCNJ8	2.42e-06	200	48	5	f0818821c495022569aef2c1886d9f2446dc027e
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RERG FN1 AEBP1 TNXB FREM1	2.42e-06	200	48	5	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RERG FN1 AEBP1 TNXB FREM1	2.42e-06	200	48	5	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RERG FN1 AEBP1 TNXB FREM1	2.42e-06	200	48	5	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RERG FN1 AEBP1 TNXB FREM1	2.42e-06	200	48	5	34f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RERG KIRREL3 ALDH1A2 ARNT2	1.90e-05	147	48	4	989a48bda98fbff398985397a6b1189a4cbc80e7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RERG KIRREL3 ALDH1A2 ARNT2	1.90e-05	147	48	4	f6681c849c4c06154548bd29a094f202d1c946c2
ToppCell	RV-13._Vascular_Smooth_Muscle\|RV / Chamber and Cluster_Paper	ACTG2 RERG FN1 ADAMTS9	2.72e-05	161	48	4	47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell	critical-Myeloid-Mast_cell\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MAG CNRIP1 AEBP1 FREM1	2.99e-05	165	48	4	34a1cc6ccd46c059354e8fbde1ac69f202695a4e
ToppCell	356C-Endothelial_cells-Endothelial-F_(Lymphatics)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	OLFML2A ADAMTS9 TNXB IPO11	3.06e-05	166	48	4	5ba45407a47207ff01e4a3f9f5d91d8247fe9b6f
ToppCell	356C-Endothelial_cells-Endothelial-F_(Lymphatics)\|356C / Donor, Lineage, Cell class and subclass (all cells)	OLFML2A ADAMTS9 TNXB IPO11	3.06e-05	166	48	4	6bd5aa205b6e4b88ba9f8cd0999e2191d7d1d16c
ToppCell	NS-critical-d_07-13-Myeloid-Mast_cell\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MAG CNRIP1 AEBP1 FREM1	3.14e-05	167	48	4	8a14fd980d8ebe8ef0216221f619d31aaa27ff15
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACTG2 ALDH1A2 AEBP1 TNXB	3.14e-05	167	48	4	784776d1fcc098f84d3c2eca58fa56cb9428f434
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RERG KIRREL3 ALDH1A2 ARNT2	3.21e-05	168	48	4	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	OLFML2A AEBP1 IPO11 TAGLN3	3.29e-05	169	48	4	f077e39e41fffe7672541f5b72b80faaf56c597c
ToppCell	PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	OLFML2A AEBP1 IPO11 TAGLN3	3.36e-05	170	48	4	35e3945d8a540a3e2cec1b559316265aaad023d1
ToppCell	PND01-Endothelial-Endothelial_lymphatic\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	OLFML2A AEBP1 IPO11 TAGLN3	3.36e-05	170	48	4	0ea625abaa25bab93b70b7000e8f90d5c0f9a0fb
ToppCell	PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	OLFML2A AEBP1 IPO11 TAGLN3	3.36e-05	170	48	4	0b5ddc7d452db0a389927a367914f7d257703f7e
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	UNC13C ALDH1A2 AEBP1 TNXB	3.60e-05	173	48	4	ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	UNC13C ALDH1A2 AEBP1 TNXB	3.60e-05	173	48	4	3725525b99a6011eda2ff5459b4fd2e1eab1f090
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	UNC13C ALDH1A2 AEBP1 TNXB	3.60e-05	173	48	4	30d67738633493d47f06ae452424382f069b6c0a
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	UNC13C ALDH1A2 AEBP1 TNXB	3.68e-05	174	48	4	a9c6edf5c3fc119c24425f921c5566a8356c30fe
ToppCell	facs-Heart-RV-24m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRKAR1B RERG KCNJ8 TAGLN3	3.76e-05	175	48	4	bfac175b79bb7d3d81074a2407c206a7647ee75d
ToppCell	facs-Heart-RV-24m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRKAR1B RERG KCNJ8 TAGLN3	3.76e-05	175	48	4	c94fb35bbac95123201ca87ca835aecaefc0c490
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	SEC24D ALDH1A2 AEBP1 TNXB	3.85e-05	176	48	4	08f94b78b27feeb113dbfadbfa7fe34d08b2809b
ToppCell	3'_v3-blood-Mast-Mast_cell_granulo-myelo\|blood / Manually curated celltypes from each tissue	CNRIP1 UNC13C FREM1 GPR82	3.85e-05	176	48	4	d421b6b8e13894dbcf29548c0a6516c3dee8f9b1
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ACTG2 OLFML2A FN1 PCDHB16	4.02e-05	178	48	4	9fc5688cf705a74398d24e10e0aab4758612e72b
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6\|TCGA-Ovary / Sample_Type by Project: Shred V9	CNRIP1 ACTG2 FN1 AEBP1	4.02e-05	178	48	4	142879e9393e721f9b05a6bb46995c9d6d713c95
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	OLFML2A ALDH1A2 AEBP1 TNXB	4.02e-05	178	48	4	cda7695411655bd6d0ba69e5041ca7530a9dad3a
ToppCell	Bronchial_Biopsy-Mesenchymal-Smooth_muscle\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	ACTG2 FN1 AEBP1 KCNJ8	4.20e-05	180	48	4	7085a851807e6a833965e1366946db0bbc5174e2
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	ACTG2 RERG FN1 AEBP1	4.20e-05	180	48	4	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KCNJ8 PCDHB16 IPO11 TAGLN3	4.29e-05	181	48	4	b0fff0defba9aea6fba36e378b05a59986e2573a
ToppCell	critical-Myeloid-Mast_cell\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MAG CNRIP1 AEBP1 FREM1	4.29e-05	181	48	4	f0d81ae74d3f32979624a94b2ef93774831a7970
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KCNJ8 PCDHB16 IPO11 TAGLN3	4.29e-05	181	48	4	cc77ac0e223e012767222e45c5dcadc246d1aa7c
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KCNJ8 PCDHB16 IPO11 TAGLN3	4.29e-05	181	48	4	ecd52f33841f4e9d946a4edad0d58da9b0cc5ffa
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ACTG2 OLFML2A FN1 KCNJ8	4.39e-05	182	48	4	fc4a5bf784705efe7965ce43ac23c2a8e602e90a
ToppCell	droplet-Heart-HEART-1m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RERG MYCBPAP KCNJ8 TAGLN3	4.39e-05	182	48	4	c84f44391932080df31c8765e363c3dff64b2bd1
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RERG FN1 ADAMTS9 TNXB	4.39e-05	182	48	4	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	RA-13._Vascular_Smooth_Muscle\|RA / Chamber and Cluster_Paper	ACTG2 RERG FN1 ADAMTS9	4.48e-05	183	48	4	818fd886e0188091310825f9145fa53328f2c979
ToppCell	tumor_Lung-Fibroblasts-Pericytes\|tumor_Lung / Location, Cell class and cell subclass	ACTG2 OLFML2A ADAMTS9 KCNJ8	4.48e-05	183	48	4	a03dd563af9b15cb1f5de5732a229405a9f82d84
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RERG KIRREL3 SRGAP2 ALDH1A2	4.48e-05	183	48	4	848fc6dd129150897ee339343e83c645b6e779eb
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RERG KIRREL3 SRGAP2 ALDH1A2	4.48e-05	183	48	4	7c4b775f351794a3de06bd503eecbc8ae8577c44
ToppCell	RA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	ACTG2 RERG FN1 ADAMTS9	4.48e-05	183	48	4	cae2ee08f985a6f005b4b8e959e465350315156a
ToppCell	COPD-Stromal-Pericyte\|COPD / Disease state, Lineage and Cell class	ACTG2 AEBP1 ADAMTS9 KCNJ8	4.58e-05	184	48	4	a56264a22dfc2d3672b20134ab7c3c7c23da5ae1
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RERG KIRREL3 FN1 TNXB	4.67e-05	185	48	4	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
Drug	Gramine [87-52-5]; Down 200; 23uM; MCF7; HT_HG-U133A	BAZ1B SEC24D ATP9B RERE FN1 NBEAL2	3.63e-06	198	48	6	2799_DN
Drug	Convolamine hydrochloride [500-56-1]; Down 200; 11.8uM; PC3; HT_HG-U133A	BAZ1B SEMA4D SEC24D PLXNC1 EMSY TAGLN3	3.74e-06	199	48	6	5876_DN
Drug	Verteporfin [129497-78-5]; Down 200; 2.8uM; HL60; HT_HG-U133A	SEMA4D PTPRA PLEC FN1 NBEAL2	2.16e-05	160	48	5	6133_DN
Drug	phillyrin	FN1 SUPT16H	2.60e-05	4	48	2	CID000101712
Drug	Pinacidil [85371-64-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A	ACTG2 ADCK2 PLEC CLCN5 C2orf68	5.04e-05	191	48	5	5456_DN
Drug	Tropicamide [1508-75-4]; Down 200; 14uM; PC3; HT_HG-U133A	BAZ1B SEMA4D SET FN1 TAGLN3	5.29e-05	193	48	5	4280_DN
Drug	Chlorpheniramine maleate [113-92-8]; Up 200; 10.2uM; PC3; HT_HG-U133A	PRKAR1B BAZ1B SEMA4D RERE PTPRA	5.29e-05	193	48	5	2055_UP
Drug	Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A	PRKAR1B OLFML2A SEMA4D RERE EMSY	5.42e-05	194	48	5	5384_DN
Drug	Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; HL60; HG-U133A	ADCK2 SRGAP2 FMO4 FN1 NBEAL2	5.42e-05	194	48	5	1422_UP
Drug	Cinchonine [118-10-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A	SEMA4D RERE PTPRA PLEC EMSY	5.42e-05	194	48	5	4107_DN
Drug	Ivermectin [70288-86-7]; Down 200; 4.6uM; MCF7; HT_HG-U133A	ACTG2 ADCK2 PTPRA C2orf68 EMSY	5.42e-05	194	48	5	2213_DN
Drug	Methoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; MCF7; HT_HG-U133A	PRKAR1B SEMA4D FN1 CLCN5 NBEAL2	5.42e-05	194	48	5	2893_UP
Drug	Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A	BAZ1B ADCK2 SEC24D RERE C2orf68	5.56e-05	195	48	5	6059_DN
Drug	(-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A	BAZ1B OLFML2A CLCN5 NBEAL2 EMSY	5.56e-05	195	48	5	3571_DN
Drug	Tranexamic acid [1197-18-8]; Up 200; 25.4uM; PC3; HT_HG-U133A	BAZ1B PTPRA EMSY KCNJ8 TAGLN3	5.56e-05	195	48	5	2085_UP
Drug	Norcyclobenzaprine [303-50-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A	BAZ1B ADCK2 FMO4 CLCN5 C2orf68	5.70e-05	196	48	5	4776_DN
Drug	Fusidic acid sodium salt [751-94-0]; Up 200; 7.4uM; PC3; HT_HG-U133A	MAG ACTG2 ATP9B RERE EMSY	5.70e-05	196	48	5	6754_UP
Drug	Bemegride [64-65-3]; Down 200; 25.8uM; MCF7; HT_HG-U133A	ACTG2 OLFML2A SEC24D RERE FN1	5.70e-05	196	48	5	3389_DN
Drug	Azaperone [1649-18-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A	BAZ1B OLFML2A SRGAP2 PTPRA NBEAL2	5.83e-05	197	48	5	3573_DN
Drug	Citalopram hydrobromide [59729-32-7]; Down 200; 1uM; PC3; HT_HG-U133A	BAZ1B OLFML2A SEC24D FN1 KCNJ8	5.83e-05	197	48	5	3820_DN
Drug	Cefixime [79350-37-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A	PRKAR1B ACTG2 OLFML2A ATP9B EMSY	5.83e-05	197	48	5	3247_DN
Drug	Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; PC3; HT_HG-U133A	SEC24D NFS1 CLCN5 PLXNC1 EMSY	5.83e-05	197	48	5	5867_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A	FN1 AEBP1 ADAMTS9 PLXNC1 KCNJ8	5.83e-05	197	48	5	3940_UP
Drug	Cyproterone acetate [427-51-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	PRKAR1B OLFML2A ATP9B PTPRA CLCN5	5.83e-05	197	48	5	3545_DN
Drug	estradiol, USP; Up 200; 0.1uM; PC3; HT_HG-U133A	BAZ1B SEC24D RERE FN1 NBEAL2	5.98e-05	198	48	5	1208_UP
Drug	2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; MCF7; HT_HG-U133A	ACTG2 ADCK2 NBEAL2 KCNJ8 TAGLN3	5.98e-05	198	48	5	5422_UP
Drug	Vigabatrin [60643-86-9]; Down 200; 31uM; PC3; HT_HG-U133A	BAZ1B ADCK2 FMO4 PLEC TAGLN3	5.98e-05	198	48	5	6314_DN
Drug	Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; MCF7; HT_HG-U133A	PRKAR1B SEC24D PTPRA NFS1 C2orf68	5.98e-05	198	48	5	6259_DN
Drug	Evoxine [522-11-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A	PRKAR1B BAZ1B SEMA4D SEC24D ATP9B	5.98e-05	198	48	5	4704_DN
Drug	LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	OLFML2A SEMA4D SEC24D RERE EMSY	5.98e-05	198	48	5	996_DN
Drug	Lobeline alpha (-) hydrochoride [134-63-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A	ACTG2 OLFML2A ADCK2 PLXNC1 TAGLN3	6.12e-05	199	48	5	2763_UP
Drug	Racecadotril [81110-73-8]; Down 200; 10.4uM; HL60; HG-U133A	PPME1 ADCK2 ATP9B FN1 NPEPPS	6.12e-05	199	48	5	1782_DN
Drug	Pentoxifylline [6493-05-6]; Down 200; 14.4uM; PC3; HT_HG-U133A	ACTG2 OLFML2A FMO4 C2orf68 KCNJ8	6.12e-05	199	48	5	2127_DN
Drug	Meclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; MCF7; HT_HG-U133A	PRKAR1B BAZ1B RERE PLEC AEBP1	6.12e-05	199	48	5	4982_UP
Drug	Coralyne chloride hydrate [38989-38-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A	SEMA4D RERE PLEC PLXNC1 C2orf68	6.12e-05	199	48	5	2652_UP
Drug	Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A	PRKAR1B OLFML2A SEC24D ATP9B PLEC	6.12e-05	199	48	5	7339_DN
Drug	Moricizine hydrochloride [31883-05-3]; Down 200; 8.6uM; MCF7; HT_HG-U133A	PRKAR1B ADCK2 ATP9B EMSY TAGLN3	6.27e-05	200	48	5	6000_DN
Drug	Hesperidin [520-26-3]; Up 200; 6.6uM; MCF7; HT_HG-U133A	BAZ1B SEMA4D SEC24D FMO4 C2orf68	6.27e-05	200	48	5	2648_UP
Drug	Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; PC3; HT_HG-U133A	PRKAR1B SEMA4D CLCN5 PLXNC1 NBEAL2	6.27e-05	200	48	5	6679_DN
Drug	1tjp	ACTG2 ALDH1A2 PTPRA FN1	1.05e-04	116	48	4	CID005459371
Drug	2-butenedinitrile	PLEC FN1	1.55e-04	9	48	2	CID000012994
Drug	methylselenic acid	ACTG2 OLFML2A SEC24D FN1 KCNJ8 POLR2H	2.18e-04	412	48	6	ctd:C008493
Drug	nitrogen peroxide	SEMA4D SET	4.49e-04	15	48	2	CID003032552
Drug	ethyl methacrylate	RERE FN1	5.13e-04	16	48	2	CID000007343
Drug	Methamphetamine	BAZ1B ADCK2 SRGAP2 ALDH1A2 PLEC FN1 ADAMTS9 EMSY TAGLN3 ARNT2	5.74e-04	1401	48	10	ctd:D008694
Drug	Zardaverine [101975-10-4]; Up 200; 15uM; PC3; HT_HG-U133A	PRKAR1B ADCK2 PLXNC1 ARNT2	6.47e-04	187	48	4	4209_UP
Drug	fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A	OLFML2A ADCK2 PLEC EMSY	6.47e-04	187	48	4	1662_UP
Drug	rosiglitazone; Down 200; 10uM; PC3; HT_HG-U133A	PRKAR1B ACTG2 SEMA4D TAGLN3	6.47e-04	187	48	4	4457_DN
Drug	lomustine; Down 200; 100uM; PC3; HT_HG-U133A	TSPAN12 PLEC C2orf68 KCNJ8	6.60e-04	188	48	4	7050_DN
Drug	16-phenyl tetranor Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A	PRKAR1B SEC24D NBEAL2 EMSY	6.86e-04	190	48	4	7546_UP
Drug	Ebselen [60940-34-3]; Up 200; 14.6uM; MCF7; HT_HG-U133A	OLFML2A FN1 PLXNC1 EMSY	6.86e-04	190	48	4	3458_UP
Drug	Ethopropazine hydrochloride [1094-08-2]; Down 200; 11.4uM; MCF7; HT_HG-U133A	PTPRA PLEC FN1 C2orf68	6.86e-04	190	48	4	5296_DN
Drug	Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A	BAZ1B SEMA4D SEC24D SET	7.00e-04	191	48	4	4303_DN
Drug	Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A	PRKAR1B BAZ1B SEC24D ATP9B	7.00e-04	191	48	4	6024_DN
Drug	Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A	BAZ1B ACTG2 OLFML2A C2orf68	7.14e-04	192	48	4	4395_DN
Drug	Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; PC3; HT_HG-U133A	BAZ1B OLFML2A PTPRA EMSY	7.14e-04	192	48	4	2123_UP
Drug	Clindamycin hydrochloride [21462-39-5]; Up 200; 8.6uM; MCF7; HT_HG-U133A	BAZ1B ACTG2 SEC24D PLXNC1	7.14e-04	192	48	4	2219_UP
Drug	Ambroxol hydrochloride [23828-92-4]; Down 200; 9.6uM; HL60; HG-U133A	BAZ1B PTPRA NFS1 FN1	7.14e-04	192	48	4	1623_DN
Drug	Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A	BAZ1B FMO4 CLCN5 NBEAL2	7.28e-04	193	48	4	1148_UP
Drug	Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; PC3; HT_HG-U133A	SEMA4D ADCK2 SEC24D RERE	7.28e-04	193	48	4	7147_UP
Drug	Procaine hydrochloride [51-05-8]; Down 200; 14.6uM; MCF7; HT_HG-U133A	SEMA4D FMO4 PLEC C2orf68	7.28e-04	193	48	4	5430_DN
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A	SEMA4D RERE PTPRA C2orf68	7.28e-04	193	48	4	3412_DN
Drug	ICI 182,780; Down 200; 1uM; PC3; HT_HG-U133A	BAZ1B PTPRA FN1 CLCN5	7.42e-04	194	48	4	4429_DN
Drug	Gly-His-Lys acetate salt; Down 200; 1uM; MCF7; HT_HG-U133A	BAZ1B FMO4 PTPRA EMSY	7.42e-04	194	48	4	6575_DN
Drug	2-propylpentanoic acid; Down 200; 500uM; HL60; HT_HG-U133A	BAZ1B ATP9B FN1 CLCN5	7.42e-04	194	48	4	6199_DN
Drug	15d-PGJ2; Down 200; 10uM; PC3; HT_HG-U133A	SEMA4D PLXNC1 C2orf68 TAGLN3	7.42e-04	194	48	4	4455_DN
Drug	trifluoperazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A	ATP9B FN1 PLXNC1 EMSY	7.42e-04	194	48	4	2684_DN
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A	BAZ1B ACTG2 SEC24D PLEC	7.42e-04	194	48	4	3539_DN
Drug	Acyclovir [59277-89-3]; Down 200; 17.8uM; MCF7; HT_HG-U133A	ACTG2 RERE PLEC CLCN5	7.42e-04	194	48	4	5278_DN
Drug	Dirithromycin [62013-04-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A	PTPRA FN1 NBEAL2 EMSY	7.42e-04	194	48	4	7446_DN
Drug	ICI 182,780; Up 200; 1uM; PC3; HT_HG-U133A	PRKAR1B BAZ1B ADCK2 EMSY	7.42e-04	194	48	4	1205_UP
Drug	Dihydroergotoxine mesylate [8067-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A	PRKAR1B SEMA4D C2orf68 NBEAL2	7.42e-04	194	48	4	2793_DN
Drug	Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; PC3; HT_HG-U133A	ADCK2 FN1 CLCN5 EMSY	7.42e-04	194	48	4	6642_DN
Drug	Flumethasone [2135-17-3]; Down 200; 9.8uM; PC3; HT_HG-U133A	BAZ1B ATP9B SET TAGLN3	7.42e-04	194	48	4	4272_DN
Drug	Quinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A	RERE FMO4 EMSY KCNJ8	7.42e-04	194	48	4	4529_DN
Drug	S(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; MCF7; HT_HG-U133A	BAZ1B RERE FN1 PLXNC1	7.56e-04	195	48	4	3393_DN
Drug	Tetramisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A	BAZ1B OLFML2A C2orf68 EMSY	7.56e-04	195	48	4	4412_DN
Drug	5666823; Down 200; 100uM; MCF7; HG-U133A	PRKAR1B FN1 NBEAL2 TP53BP1	7.56e-04	195	48	4	609_DN
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; PC3; HT_HG-U133A	SEMA4D SRGAP2 RERE NBEAL2	7.56e-04	195	48	4	5117_DN
Drug	Rolipram [61413-54-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A	BAZ1B ACTG2 PLEC ARNT2	7.56e-04	195	48	4	5330_UP
Drug	Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A	PRKAR1B BAZ1B SEMA4D PLXNC1	7.56e-04	195	48	4	2278_DN
Drug	SB 202190; Down 200; 1uM; MCF7; HT_HG-U133A	BAZ1B OLFML2A FMO4 C2orf68	7.56e-04	195	48	4	6887_DN
Drug	Antipyrine [60-80-0]; Down 200; 21.2uM; PC3; HT_HG-U133A	PRKAR1B SEMA4D RERE PLXNC1	7.56e-04	195	48	4	4251_DN
Drug	Prazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A	PRKAR1B FN1 AEBP1 C2orf68	7.56e-04	195	48	4	5416_DN
Drug	Desipramine hydrochloride [58-28-6]; Up 200; 13.2uM; MCF7; HT_HG-U133A	SEC24D RERE PLXNC1 TAGLN3	7.56e-04	195	48	4	3212_UP
Drug	Ticarcillin sodium [4697-14-7]; Down 200; 9.4uM; HL60; HT_HG-U133A	BAZ1B PTPRA CLCN5 EMSY	7.56e-04	195	48	4	6146_DN
Drug	Hippeastrine hydrobromide [22352-41-6]; Down 200; 10uM; PC3; HT_HG-U133A	TSPAN12 BAZ1B ADCK2 KCNJ8	7.56e-04	195	48	4	7381_DN
Drug	Leucomisine [17946-87-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A	PRKAR1B BAZ1B FMO4 CLCN5	7.56e-04	195	48	4	3546_DN
Drug	Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A	PRKAR1B ADCK2 PTPRA EMSY	7.56e-04	195	48	4	2311_DN
Drug	Amiodarone hydrochloride [19774-82-4]; Down 200; 5.8uM; MCF7; HT_HG-U133A	ACTG2 ADCK2 RERE NBEAL2	7.56e-04	195	48	4	5618_DN
Drug	Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; PC3; HT_HG-U133A	OLFML2A SEMA4D RERE PLXNC1	7.56e-04	195	48	4	4199_DN
Drug	Ramipril [87333-19-5]; Up 200; 9.6uM; PC3; HT_HG-U133A	BAZ1B ACTG2 ADCK2 EMSY	7.56e-04	195	48	4	7144_UP
Drug	AH23848 hemicalcium salt hydrate; Down 200; 1uM; MCF7; HT_HG-U133A	BAZ1B OLFML2A FMO4 C2orf68	7.56e-04	195	48	4	6890_DN
Drug	Butylparaben [94-26-8]; Down 200; 20.6uM; HL60; HT_HG-U133A	BAZ1B ATP9B RERE CLCN5	7.71e-04	196	48	4	3069_DN
Drug	Decamethonium bromide [541-22-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ADCK2 SEC24D RERE NBEAL2	7.71e-04	196	48	4	7353_DN
Drug	(1)-Nipecotic acid [498-95-3]; Down 200; 31uM; HL60; HT_HG-U133A	ATP9B PLEC NFS1 NBEAL2	7.71e-04	196	48	4	3121_DN
Drug	5255229; Up 200; 13uM; MCF7; HT_HG-U133A_EA	PRKAR1B ATP9B CLCN5 C2orf68	7.71e-04	196	48	4	833_UP
Drug	Nomegestrol acetate [58652-20-3]; Down 200; 10.8uM; MCF7; HT_HG-U133A	BAZ1B ACTG2 OLFML2A ADCK2	7.71e-04	196	48	4	5461_DN
Drug	Thioproperazine dimesylate [2347-80-0]; Down 200; 6.2uM; MCF7; HT_HG-U133A	PRKAR1B BAZ1B ACTG2 PLEC	7.71e-04	196	48	4	2236_DN
Drug	Retrorsine [480-54-6]; Up 200; 11.4uM; PC3; HT_HG-U133A	PRKAR1B ACTG2 FMO4 FN1	7.71e-04	196	48	4	6601_UP
Disease	congenital diaphragmatic hernia (is_implicated_in)	ALDH1A2 FREM1	1.42e-05	4	46	2	DOID:3827 (is_implicated_in)
Disease	1-palmitoyl-GPE (16:0) measurement	ALDH1A2 TP53BP1	4.97e-05	7	46	2	EFO_0800245
Disease	asthma, chronic obstructive pulmonary disease	RERE PLXNC1 EMSY	6.60e-05	50	46	3	EFO_0000341, MONDO_0004979
Disease	asthma	SEMA4D UNC13C SRGAP2 RERE ADAMTS9 PLXNC1 EMSY	1.52e-04	751	46	7	MONDO_0004979
Disease	diet measurement	LENG8 BAZ1B SEMA4D KIRREL3 UNC13C RERE PTPRA PCDHB16	1.95e-04	1049	46	8	EFO_0008111
Disease	behavioural disinhibition measurement	KIRREL3 UNC13C FN1	2.21e-04	75	46	3	EFO_0006946
Disease	cortical thickness	SEMA4D SRGAP2 ALDH1A2 RERE PLEC ADAMTS9 PLXNC1 PCDHB16	2.91e-04	1113	46	8	EFO_0004840
Disease	urate measurement, bone density	PRKAR1B KIRREL3 DHX33 PLXNC1 TNXB FREM1	3.82e-04	619	46	6	EFO_0003923, EFO_0004531
Disease	serum gamma-glutamyl transferase measurement	BAZ1B RERG ALDH1A2 CDC42BPB NBEAL2 EMSY TP53BP1	4.99e-04	914	46	7	EFO_0004532
Disease	alpha fetoprotein measurement	SEMA4D NPEPPS TP53BP1	5.16e-04	100	46	3	EFO_0010583
Disease	atopic eczema	RERE PLXNC1 TNXB EMSY	6.40e-04	252	46	4	EFO_0000274
Disease	severe acute respiratory syndrome, COVID-19	KIRREL3 UNC13C SRGAP2 CLCN5 ARNT2	6.41e-04	447	46	5	EFO_0000694, MONDO_0100096
Disease	nephrotic syndrome (implicated_via_orthology)	KIRREL3 COQ8B	6.42e-04	24	46	2	DOID:1184 (implicated_via_orthology)
Disease	cerebral white matter volume change measurement, age at assessment	NPEPPS FREM1	8.76e-04	28	46	2	EFO_0008007, EFO_0021499
Disease	nicotine use, generational effect measurement, illegal drug consumption, non-substance related disinhibited behaviour, alcohol drinking, alcohol dependence	RERG PLXNC1	9.40e-04	29	46	2	EFO_0004329, EFO_0005430, EFO_0005431, EFO_0005432, EFO_0008364, MONDO_0007079
Disease	lysophosphatidylethanolamine 18:1 measurement	UNC13C ALDH1A2	1.29e-03	34	46	2	EFO_0010368
Disease	C-reactive protein measurement, high density lipoprotein cholesterol measurement	BAZ1B ALDH1A2	1.29e-03	34	46	2	EFO_0004458, EFO_0004612
Disease	phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement	SEMA4D ALDH1A2 NPEPPS TP53BP1	1.33e-03	307	46	4	EFO_0004612, EFO_0020946
Disease	respiratory system disease	RERE PLXNC1 EMSY	1.51e-03	145	46	3	EFO_0000684

Protein segments in the cluster

Peptide	Gene	Start	Entry
PFVTREVLVETYEES	ADCK2	391	Q7Z695
TAGSRIFVEESIYEE	ALDH1A2	321	O94788
SETETYTEVVTEFGT	AEBP1	1081	Q8IUX7
LGYVEETSEFEARVI	BAZ1B	1071	Q9UIG0
ERGYSFVTTAEREIV	ACTG2	196	P63267
EYEADSGEVTSVIVY	C2orf68	111	Q2NKX9
FVVAAETGRVIYVSD	ARNT2	151	Q9HBZ2
VEVENETGKDTFRVY	PPME1	56	Q9Y570
TVYYSVIEATEGEES	GPR82	171	Q96P67
SIVTEEEGVYSVDYS	KCNJ8	326	Q15842
VTVNESEREFVYSER	MAG	451	P20916
GRFTTEEEVDYTVEK	NFS1	411	Q9Y697
PVYESRAGVTEETEF	ATP9B	556	O43861
GVIVRDESTAEITFY	ATP9B	641	O43861
SYVFTEVGEGVTFER	IPO11	301	Q9UI26
TVQGIRTEFTVEVYE	LENG8	611	Q96PV6
FTGYRVESEVDTELE	PLXNC1	846	O60486
TVEENIDVVIFTTGY	FMO4	316	P31512
EVVITSEYIFATDVD	FREM1	906	Q5H8C1
VTVYSEYGVDVFDVR	CDC42BPB	1476	Q9Y5S2
VAFVVGEYDFVETRS	NPEPPSL1	246	A6NEC2
GSYSVVEETERGSFV	PCDHB16	31	Q9NRJ7
VVEYSGSETAVERIN	ADAMTS9	826	Q9P2N4
VSASDTVSGFRVEYE	FN1	741	P02751
TVSGFRVEYELSEEG	FN1	746	P02751
DRVVYTGTYDTEGVT	CNRIP1	81	Q96F85
EDVETIISETTYSGF	CLCN5	676	P51795
VGYTVRFDDVTSEDT	DHX33	151	Q9H6R0
REFGTEFTDHYIEVV	COQ8B	391	Q96D53
SAEVYTEEDAVSYVR	PRKAR1B	101	P31321
GRYTVETISTEEGVI	KIRREL3	466	Q8IZU9
VVESELVAEYITTER	EMSY	826	Q7Z589
VAFVVGEYDFVETRS	NPEPPS	246	P55786
SGRARVEDFYTVETV	OLFML2A	66	Q68BL7
VEDFYTVETVSSGTD	OLFML2A	71	Q68BL7
RVSVEDVTVLVDYTV	PTPRA	366	P18433
ETYGVRTTDIFQTVD	TAGLN3	101	Q9UI15
VYFYDGSTERVETEE	NBEAL2	1946	Q6ZNJ1
TRVEVTEFEDIKSGY	SET	121	Q01105
YERTDTGEITSYITE	RERE	86	Q9P2R6
TGEITSYITEDDVVY	RERE	91	Q9P2R6
TEVSVEYEFVFRVLI	SEMA4D	236	Q92854
TDVQFYTEVGEITTD	SUPT16H	736	Q9Y5B9
EQEETSAIRVGFITY	SEC24D	476	O94855
VLVYDITDRGSFEEV	RERG	81	Q96A58
VTEERFEYVESVVYQ	UNC13C	326	Q8NB66
YIVVQDTEDGVVERS	SRGAP2	781	O75044
YEVTVVSVRGFEESE	TNXB	3821	P22105
AVTVEDYTVFERSQG	MYCBPAP	366	Q8TBZ2
VYRIEGDETSTEAAT	POLR2H	96	P52434
TRVITDVYYVDGTEV	TP53BP1	1251	Q12888
DVYYVDGTEVERKVT	TP53BP1	1256	Q12888
TTQVYTEEETRRAFE	PLEC	3691	Q15149
TAETRVEEAVILTYF	TSPAN12	46	O95859